CL
ClearPoint Neuro, Inc.
CLPT · NASDAQ
$13.72 +0.51% (+$0.07)
1M -11.02%
Market Cap $404.3M
P/E Ratio -
Div. Yield -
ROE 188.09%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 9.56x
P/B 37.51x
P/E N/A
Growth
78 /100
Growing Rev. growth 21.62%
Book val. growth 8.76%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 62.61%
FCF margin 74.01%
Net margin 81.76%
Quality
6 /100
Poor ROIC 40.49%
Asset turnover 0.49x
ROE 188.09%
Debt
23 /100
High Debt/Equity 5.93x
Int. coverage -7.63x
Current ratio 4.73x
Stability
64 /100
Moderate Beta 1.27x
Profitable years 0
Rev. volatility 8.03%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CLPT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Joseph Michael Burnett
Employees
172
Headquarters
Solana Beach
Upcoming events
05 NOV
Earnings
Upcoming earnings report